investigation from our study group including more than 300 patients affected by early stage ovarian cancer, suggested the safety of conservative approach in early stage ovarian cancer. Moreover, a sub-analysis of our data suggested that the execution of FSS rather than RCS does not influence outcomes of high-risk ovarian cancer [2] . Using a propensity-matched comparison (in order to minimize possible selection bias) we observed that high-risk ovarian cancers are characterized by similar disease-free and overall survivals than patients undergoing RCS [2] . Similarly, data of 221 patients, undergoing FSS in 30 institutions (belonging to the Gynecologic Cancer Study Group of the Japan Clinical Oncology Group), suggested that stage IC ovarian cancer or patients with unfavorable histology (e.g., clear cell) may benefit from conservative approach [5] . In agreement with others, this study reported that salvage therapy following local (ovarian) recurrence is highly effective, achieving an excellent oncologic control [5, 6] .
Therefore, owing the current evidence and the impact of RCS on quality of life of young women who wish to preserve their childbearing potential and endocrine function, we believe that FSS should not also be denied in high-risk ovarian cancer. Depriving a young woman of her reproductive function with unnecessary surgical procedures should be a real source of concerns. Accurate counseling and a strict followup are needed. Further multi-institutional prospective welldesigned studies are warranted in order to improve patients' oncologic outcomes and their quality of life.
